Merrimack Pharmaceuticals Inc
Annual report (10-K)
Latest 10-K/A filed Mar 21, 2024. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Merrimack Pharmaceuticals Inc
| Name | Roles | Filings |
|---|---|---|
| Ledo Capital, LLC | - | 10 |
| Levy Noah G. | Director | 10 |
| Newtyn Partners, LP | - | 10 |
| Newtyn Te Partners, LP | - | 10 |
| Newtyn Capital Partners, LP | - | 10 |
All filings
53 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|